Content provided by The Long Run with Luke Timmerman and Timmerman Report. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Long Run with Luke Timmerman and Timmerman Report or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Ep135: John Maraganore on Developing a New Class of Medicines
Manage episode 362779587 series 2396963
Content provided by The Long Run with Luke Timmerman and Timmerman Report. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Long Run with Luke Timmerman and Timmerman Report or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.
…
continue reading
178 episodes
Manage episode 362779587 series 2396963
Content provided by The Long Run with Luke Timmerman and Timmerman Report. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Long Run with Luke Timmerman and Timmerman Report or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.
…
continue reading
178 episodes
All episodes
×T
The Long Run with Luke Timmerman


1 Ep180: John Rinn on Discovering Drugs Based on Long Non-Coding RNA 1:10:45
1:10:45
Play Later
Play Later
Lists
Like
Liked1:10:45
John Rinn, professor at the University of Colorado and co-founder of Lincswitch Therapeutics, on exploring long non-coding RNA.
T
The Long Run with Luke Timmerman


1 Ep179: Ethan Weiss & Josh Lehrer on a New Idea for Cardiovascular Disease & Diabetes 1:03:25
1:03:25
Play Later
Play Later
Lists
Like
Liked1:03:25
Marea Therapeutics CEO Josh Lehrer and CSO Ethan Weiss on a new angle of attack against cardiovascular disease and diabetes.
T
The Long Run with Luke Timmerman


1 Ep178: Peyton Greenside on ML-Guided Biologics Discovery 1:02:56
1:02:56
Play Later
Play Later
Lists
Like
Liked1:02:56
Peyton Greenside, co-founder and CEO of BigHat Biosciences, on machine-learning guided biologic drug discovery.
T
The Long Run with Luke Timmerman


1 Ep177: Kevin Parker on Finding Cancer Drug Targets 58:13
58:13
Play Later
Play Later
Lists
Like
Liked58:13
Kevin Parker, CEO of Cartography Biosciences, on finding new cancer drug targets.
T
The Long Run with Luke Timmerman


1 Ep176: David Roblin on Building a TechBio Company 1:19:28
1:19:28
Play Later
Play Later
Lists
Like
Liked1:19:28
David Roblin, CEO of London-based Relation Therapeutics, on building a techbio discovery company.
T
The Long Run with Luke Timmerman


1 Ep175: Andy Scharenberg on in vivo CAR-T cell therapies 1:10:46
1:10:46
Play Later
Play Later
Lists
Like
Liked1:10:46
Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.
T
The Long Run with Luke Timmerman


1 Ep174: Najat Khan on the TechBio Movement 1:07:16
1:07:16
Play Later
Play Later
Lists
Like
Liked1:07:16
Najat Khan, chief R&D and chief commercial officer of Recursion, on using technology to improve drug discovery.
T
The Long Run with Luke Timmerman


1 Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders 57:56
57:56
Play Later
Play Later
Lists
Like
Liked57:56
Robert Blum, CEO of South San Francisco-based Cytokinetics, on building a fully integrated biopharma to treat muscle disorders.
T
The Long Run with Luke Timmerman


1 Ep172: Mostafa Ronaghi on Studying Live Cells at Scale 1:20:53
1:20:53
Play Later
Play Later
Lists
Like
Liked1:20:53
Mostafa Ronaghi, co-founder and executive board member of Cellanome, on developing technology to look at live cells and cellular interactions at scale.
T
The Long Run with Luke Timmerman


1 Ep171: Ram Aiyar on RNA Editing Medicines 1:01:48
1:01:48
Play Later
Play Later
Lists
Like
Liked1:01:48
Ram Aiyar, CEO of Cambridge, Mass.-based Korro Bio, on RNA editing medicines.
T
The Long Run with Luke Timmerman


1 Ep170: David Schenkein on Investing in the Future of Biotech 59:52
59:52
Play Later
Play Later
Lists
Like
Liked59:52
David Schenkein, general partner at GV, on investing in the future of biotech.
T
The Long Run with Luke Timmerman


1 Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines 1:02:28
1:02:28
Play Later
Play Later
Lists
Like
Liked1:02:28
Alnylam Pharmaceuticals chief scientific officer Kevin Fitzgerald on the past, present & future of RNA interference medicines.
T
The Long Run with Luke Timmerman


1 Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer 1:00:23
1:00:23
Play Later
Play Later
Lists
Like
Liked1:00:23
Jonathan Bricker, professor in the cancer prevention program at Fred Hutchinson Cancer Center, on how to quit smoking with help from tech and biotech tools.
T
The Long Run with Luke Timmerman


1 Ep167: Leslie Williams on transfer RNA therapies 1:11:28
1:11:28
Play Later
Play Later
Lists
Like
Liked1:11:28
Leslie Williams, CEO of Boston-based hC Bioscience, on developing transfer RNA therapies.
T
The Long Run with Luke Timmerman


1 Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity 1:03:35
1:03:35
Play Later
Play Later
Lists
Like
Liked1:03:35
Chris Garcia, professor at Stanford University and co-founder of several biotech startups, on using protein engineering to advance new treatments for cancer and autoimmune diseases.
Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.